Doubts about the efficacy of tolvaptan for polycystic kidney disease Reply

Ron T. Gansevoort*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

82 Downloads (Pure)
Original languageEnglish
Pages (from-to)310-311
Number of pages2
JournalCLINICAL NEPHROLOGY
Volume93
Issue number6
DOIs
Publication statusPublished - Jun-2020

Cite this